Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway

FEBS Letters

Volumn 583, Issue 22, 2009, Pages 3697-3703

  Makinoshima, Hideki ^a   Dezawa, Mari ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CC chemokine ligand 5; Gene expression; Insulin like growth factor; Mesenchymal stromal cell; Pancreatic cancer cell; Tumor microenvironment

Indexed keywords

RANTES; SOMATOMEDIN C;

ARTICLE; CANCER CELL; CELL ACTIVATION; CELL INTERACTION; COCULTURE; MESENCHYME CELL; MOLECULAR MECHANICS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; STROMA CELL;

BLOTTING, WESTERN; CELL COMMUNICATION; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINE CCL5; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUCIFERASES; MESENCHYMAL STEM CELLS; MICROSCOPY, FLUORESCENCE; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 71749087463     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.10.061     Document Type: Article

References (29)

1. Tlsty T.D., and Coussens L.M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1 (2006) 119-150
2. Wels J., Kaplan R.N., Rafii S., and Lyden D. Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 22 (2008) 559-574
3. Yoneda T., and Hiraga T. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem. Biophys. Res. Commun. 328 (2005) 679-687
4. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 6 (2006) 392-401
5. Haviv I., Polyak K., Qiu W., Hu M., and Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle 8 (2009) 589-595
6. Ostman A., and Augsten M. Cancer-associated fibroblasts and tumor growth - bystanders turning into key players. Curr. Opin. Genet. Dev. 19 (2009) 67-73
7. Ishii G., Sangai T., Sugiyama K., Ito T., Hasebe T., Endoh Y., Magae J., and Ochiai A. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 23 (2005) 699-706
8. Beckermann B.M., et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Brit. J. Cancer 99 (2008) 622-631
9. Ho I.A., Chan K.Y., Ng W.H., Guo C.M., Hui K.M., Cheang P., and Lam P.Y. Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells 27 (2009) 1366-1375
10. Lazennec G., and Jorgensen C. Concise review: adult multipotent stromal cells and cancer: risk or benefit?. Stem Cells 26 (2008) 1387-1394
11. Mishra P.J., Mishra P.J., Glod J.W., and Banerjee D. Mesenchymal stem cells: flip side of the coin. Cancer Res. 69 (2009) 1255-1258
12. Spaeth E.L., Dembinski J.L., Sasser A.K., Watson K., Klopp A., Hall B., Andreeff M., and Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE 4 (2009) e4992
13. Pittenger M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
14. Dezawa M., et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 113 (2004) 1701-1710
15. Dezawa M., Ishikawa H., Itokazu Y., Yoshihara T., Hoshino M., Takeda S., Ide C., and Nabeshima Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309 (2005) 314-317
16. Dezawa M. Insights into autotransplantation: the unexpected discovery of specific induction systems in bone marrow stromal cells. Cell Mol. Life Sci. 63 (2006) 2764-2772
17. Kelley K.M., et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28 (1996) 619-637
18. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8 (2008) 915-928
19. Baserga R., Peruzzi F., and Reiss K. The IGF-1 receptor in cancer biology. Int. J. Cancer 107 (2003) 873-877
20. Karnoub A.E., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
21. Hayase M., Kitada M., Wakao S., Itokazu Y., Nozaki K., Hashimoto N., Takagi Y., and Dezawa M. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J. Cereb. Blood Flow Metab. (2009)
22. Yang J., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 (2004) 927-939
23. Dumoulin F.L., Nischalke H.D., Leifeld L., von dem Bussche A., Rockstroh J.K., Sauerbruch T., and Spengler U. Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J. Immunol. Methods 241 (2000) 109-119
24. Nelson P.J., Kim H.T., Manning W.C., Goralski T.J., and Krensky A.M. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J. Immunol. 151 (1993) 2601-2612
25. Tan M.C., et al. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J. Immunol. 182 (2009) 1746-1755
26. Wang L., et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110 (2007) 4111-4119
27. Mira E., Lacalle R.A., Gonzalez M.A., Gomez-Mouton C., Abad J.L., Bernad A., Martinez A.C., and Manes S. A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep. 2 (2001) 151-156
28. Doerr M.E., and Jones J.I. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271 (1996) 2443-2447
29. Canonici A., et al. Insulin-like growth factor-I receptor, E-cadherin and alpha v integrin form a dynamic complex under the control of alpha-catenin. Int. J. Cancer 122 (2008) 572-582